Skip to main content

CORRECTION article

Front. Oncol., 14 April 2023
Sec. Pharmacology of Anti-Cancer Drugs
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1187014

Corrigendum: Variations in circulating levels of angiopoietin-2 over time are predictive of ramucirumab–paclitaxel therapy outcome in advanced gastric cancer: results of prospective study

This article is a correction to:

  1. Variations in Circulating Levels of Angiopoietin-2 Over Time Are Predictive of Ramucirumab–Paclitaxel Therapy Outcome in Advanced Gastric Cancer: Results of Prospective Study

    1. Read original article
Rosalba D&#x;Alessandro&#x;Rosalba D’Alessandro1†Maria Grazia Refolo&#x;Maria Grazia Refolo1†Annalisa SchirizziAnnalisa Schirizzi1Giampiero De LeonardisGiampiero De Leonardis1Rossella DonghiaRossella Donghia2Vito GuerraVito Guerra2Gianluigi GiannelliGianluigi Giannelli3Ivan Roberto LolliIvan Roberto Lolli4Maria Maddalena LaterzaMaria Maddalena Laterza5Ferdinando De VitaFerdinando De Vita6Caterina Messa*Caterina Messa1*Claudio Lotesoriere*Claudio Lotesoriere4*
  • 1Laboratory of Experimental Oncology, National Institute of Gastroenterology - IRCCS “Saverio de Bellis”, Castellana Grotte, Italy
  • 2Data Science Unit, National Institute of Gastroenterology - IRCCS “Saverio de Bellis”, Castellana Grotte, Italy
  • 3Scientific Direction, National Institute of Gastroenterology - IRCCS “Saverio de Bellis”, Castellana Grotte, Italy
  • 4Medical Oncology Unit, National Institute of Gastroenterology - IRCCS “Saverio de Bellis”, Castellana Grotte, Italy
  • 5Complex Operating Unit Oncologia, Local Health Authority Napoli 2 Nord, P.O. “S.M. delle Grazie”, Naples, Italy
  • 6Division of Medical Oncology, Department of Precision Medicine, School of Medicine, University of Study of Campania “Luigi Vanvitelli”, Naples, Italy

A Corrigendum on
Variations in circulating levels of angiopoietin-2 over time are predictive of ramucirumab–paclitaxel therapy outcome in advanced gastric cancer: results of prospective study

By D’Alessandro R, Refolo MG, Schirizzi A, De Leonardis G, Donghia R, Guerra V, Giannelli G, Lolli IR, Laterza MM, De Vita F, Messa C and Lotesoriere C (2022). Front. Oncol. 12:862116. doi: 10.3389/fonc.2022.862116

In the published article, there were errors in the author affiliations list. Instead of

“1Laboratory of Experimental Oncology, National Institute of Gastroenterology, “Saverio de Bellis” Research Hospital, Castellana Grotte, Italy; 2National Institute of Gastroenterology, “Saverio de Bellis” Research Hospital, Castellana Grotte, Italy; 3Scientific Direction, National Institute of Gastroenterology “Saverio de Bellis”, Research Hospital, Castellana Grotte, Italy; 4Medical Oncology Unit, National Institute of Gastroenterology, “Saverio de Bellis” Research Hospital, Castellana Grotte, Italy; 5Complex Operating Unit Oncologia, Local Health Authority Napoli 2 Nord, P.O. “S.M. delle Grazie”, Naples, Italy; 6Division of Medical Oncology, Department of Precision Medicine, School of Medicine, University of Study of Campania “Luigi Vanvitelli”, Naples, Italy”, the author list should have been “1Laboratory of Experimental Oncology, National Institute of Gastroenterology - IRCCS “Saverio de Bellis”, Castellana Grotte, Italy; 2Data Science Unit, National Institute of Gastroenterology - IRCCS “Saverio de Bellis”, Castellana Grotte, Italy; 3Scientific Direction, National Institute of Gastroenterology - IRCCS “Saverio de Bellis”, Castellana Grotte, Italy; 4Medical Oncology Unit, National Institute of Gastroenterology - IRCCS “Saverio de Bellis”, Castellana Grotte, Italy; 5Complex Operating Unit Oncologia, Local Health Authority Napoli 2 Nord, P.O. “S.M. delle Grazie”, Naples, Italy; 6Division of Medical Oncology, Department of Precision Medicine, School of Medicine, University of Study of Campania “Luigi Vanvitelli”, Naples, Italy”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: angiogenesis, gastric cancer, target therapy, biomarkers, cancer progression

Citation: D’Alessandro R, Refolo MG, Schirizzi A, De Leonardis G, Donghia R, Guerra V, Giannelli G, Lolli IR, Laterza MM, De Vita F, Messa C and Lotesoriere C (2023) Corrigendum: Variations in circulating levels of angiopoietin-2 over time are predictive of ramucirumab–paclitaxel therapy outcome in advanced gastric cancer: results of prospective study. Front. Oncol. 13:1187014. doi: 10.3389/fonc.2023.1187014

Received: 15 March 2023; Accepted: 06 April 2023;
Published: 14 April 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 D’Alessandro, Refolo, Schirizzi, De Leonardis, Donghia, Guerra, Giannelli, Lolli, Laterza, De Vita, Messa and Lotesoriere. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Claudio Lotesoriere, Y2xhdWRpby5sb3Rlc29yaWVyZUBpcmNjc2RlYmVsbGlzLml0; Caterina Messa, Y2F0ZXJpbmEubWVzc2FAaXJjY3NkZWJlbGxpcy5pdA==

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.